FDA National Drug Codes
Searching…
FDA National Drug Codes
Searching…
FDA National Drug Codes
Browse every product in the FDA NDC Directory below, or search by NDC, brand, generic, manufacturer or HCPCS code. Each product has its own page with package NDCs in 11-digit billing format.
177 products match “Recombi” (finished products)
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Eloctateantihemophilic factor (recombinant), fc fusion protein | — | KitIntravenous | Bioverativ Therapeutics Inc. | 71104-807 |
| Eloctateantihemophilic factor (recombinant), fc fusion protein | — | KitIntravenous | Bioverativ Therapeutics Inc. | 71104-808 |
| Eloctateantihemophilic factor (recombinant), fc fusion protein | — | KitIntravenous | Bioverativ Therapeutics Inc. | 71104-809 |
| Eloctateantihemophilic factor (recombinant), fc fusion protein | — | KitIntravenous | Bioverativ Therapeutics Inc. | 71104-810 |
| Engerix-Bhepatitis b vaccine (recombinant) | Hepatitis b virus subtype adw2 hbsag surface protein antigen 20 ug/mL | Injection, SuspensionIntramuscular |
| A-S Medication Solutions |
| 50090-1223 |
| Engerix-Bhepatitis b vaccine (recombinant) | Hepatitis b virus subtype adw2 hbsag surface protein antigen 10 ug/.5mL | Injection, SuspensionIntramuscular | GlaxoSmithKline Biologicals SA | 58160-820 |
|---|
| Engerix-Bhepatitis b vaccine (recombinant) | Hepatitis b virus subtype adw2 hbsag surface protein antigen 20 ug/mL | Injection, SuspensionIntramuscular | GlaxoSmithKline Biologicals SA | 58160-821 |
|---|
| Esperoctantihemophilic factor (recombinant), glycopegylated-exei | — | Kit | Novo Nordisk | 0169-8055 |
|---|
| Esperoctantihemophilic factor (recombinant), glycopegylated-exei | — | Kit | Novo Nordisk | 0169-8100 |
|---|
| Esperoctantihemophilic factor (recombinant), glycopegylated-exei | — | Kit | Novo Nordisk | 0169-8150 |
|---|
| Esperoctantihemophilic factor (recombinant), glycopegylated-exei | — | Kit | Novo Nordisk | 0169-8200 |
|---|
| Esperoctantihemophilic factor (recombinant), glycopegylated-exei | — | Kit | Novo Nordisk | 0169-8300 |
|---|
| Esperoctantihemophilic factor (recombinant), glycopegylated-exei | — | Kit | Novo Nordisk | 0169-8400 |
|---|
| Esperoctantihemophilic factor (recombinant), glycopegylated-exei | — | Kit | Novo Nordisk | 0169-8500 |
|---|
| Flublok Trivalent Northern Hemisphereinfluenza a virus a/missouri/11/2025 (h1n1) recombinant hemagglutinin antigen, influenza a virus a/darwin/1415/2025 (h3n2) recombinant hemagglutinin antigen, and influenza b virus b/pennsylvania/14/2025 recombinant hemagglutinin antigen | Influenza a virus a/missouri/11/2025 (H1n1) recombinant hemagglutinin antigen 45 ug/.5mL + 2 more ingredients | InjectionIntramuscular | Sanofi Vaccines US Inc. | 49281-726 |
|---|
| Gamma -12interleukin-12 human recombinant - interferon gamma-1b - | Interferon gamma-1b 4 [hp_C]/30mL; Interleukin-12 human recombinant 4 [hp_C]/30mL | Solution/ dropsOral | Guna spa | 17089-405 |
|---|
| Gardasilhuman papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant | Human papillomavirus type 6 l1 capsid protein antigen 20 ug/.5mL + 3 more ingredients | Injection, SuspensionIntramuscular | Merck Sharp & Dohme LLC | 0006-4045 |
|---|
| Gardasilhuman papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant | Human papillomavirus type 6 l1 capsid protein antigen 20 ug/.5mL + 3 more ingredients | Injection, SuspensionIntramuscular | Merck Sharp & Dohme LLC | 0006-4109 |
|---|
| Gardasil 9human papillomavirus 9-valent vaccine, recombinant | Human papillomavirus type 6 l1 capsid protein antigen 30 ug/.5mL + 8 more ingredients | Injection, SuspensionIntramuscular | Merck Sharp & Dohme LLC | 0006-4119 |
|---|
| Gardasil 9human papillomavirus 9-valent vaccine, recombinant | Human papillomavirus type 6 l1 capsid protein antigen 30 ug/.5mL + 8 more ingredients | Injection, SuspensionIntramuscular | Merck Sharp & Dohme LLC | 0006-4121 |
|---|